Moderna, Inc. News, Details, Contact, Events, Links

Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.

Click to see more

Moderna, Inc. News

Business News, Market News, News, Stocks, Wall Street PFE Stock Slightly Up, Pfizer CEO Says Omicron Vaccine to Be Ready in March

By Ibukun Ogundare January 11th, 2022

Pfizer CEO said that it is not clear if a fourth dose is required. He explained that Pfizer would conduct experiments to reach a conclusion.

Business News, Market News, News, Stocks MRNA Shares Up 9% as Moderna Starts Working on Booster Targeting Omicron Variant

By Ibukun Ogundare January 11th, 2022

According to Bancel, Moderna is working “with public health leaders around the world” to produce a booster to tackle the Omicron variant.

Business News, Indices, Market News, News, Stocks European Stock Market Edges Higher despite Persistent Omicron Fears

By Benjamin Godfrey December 27th, 2021

With the restrictions, the entire global market will slip to the downturn experienced in the first quarter and an early second quarter last year when the COVID-19 pandemic was just building its harsh momentum.